Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 2/20 | 0.35 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | RARB | P10826 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29569404 | 1.00 | RXRA (0.35) | RXRAFTOALDH1A1MAPTRECQL | |
| SCHEMBL12387988 | 0.90 | KDM4E (0.35) | RXRAFTOALDH1A1MAPTRECQL | |
| SCHEMBL12190600 | 0.90 | KDM4E (0.35) | RXRAFTOALDH1A1MAPTRECQL | |
| SCHEMBL14413579 | 0.90 | KDM4E (0.35) | RXRAFTOALDH1A1MAPTRECQL | |
| SCHEMBL16021623 | 0.88 | RXRA (0.33) | RXRAFTORARB | |
| SCHEMBL18656390 | 0.88 | RXRA (0.33) | RXRAFTORARB | |
| SCHEMBL18088472 | 0.88 | ALDH1A1 (0.35) | RXRAFTOALDH1A1MAPTRECQL | |
| SCHEMBL218400 | 0.87 | ALDH1A1 (0.37) | RXRAFTOALDH1A1MAPTRECQL | |
| SCHEMBL30062005 | 0.87 | ALDH1A1 (0.37) | RXRAFTOALDH1A1MAPTRECQL | |
| SCHEMBL19398980 | 0.87 | FTO (0.39) | FTO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 679 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4317576-A1 | FIBER-TREATING AGENT | Kao Corporation (JP) | 2024-02-07 | — | — | EP | claimed |
| US-20230149562-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | TIBA BIOTECH LLC (US) | 2023-05-18 | — | — | US | claimed |
| CN-115093559-A | Self-polymerization microporous ionomer and preparation method and application thereof | 太原理工大学 | 2022-09-23 | — | — | CN | claimed |
| US-20210284595-A1 | SPIROBIINDANE DERIVATIVES AND A PROCESS FOR PREPARATION THEREOF | RELIANCE INDUSTRIES LIMITED (IN) | 2021-09-16 | — | — | US | claimed |
| US-11117104-B2 | Composite membranes having intrinsic microporosity | IP2IPO INNOVATIONS LIMITED (GB) | 2021-09-14 | — | — | US | claimed |
| CN-110676065-B | Metal crosslinked porous carbon material, and preparation method and application thereof | 华东师范大学 | 2021-05-07 | — | — | CN | claimed |
| EP-2768605-B1 | MEMBRANES FOR SEPARATION | IP2IPO INNOVATIONS LTD (GB) | 2020-08-26 | — | — | EP | claimed |
| CN-111326349-A | PIM-1 loaded polypyrrole composite material, and preparation method and application thereof | 华东师范大学 | 2020-06-23 | — | — | CN | claimed |
| US-20200094198-A1 | COMPOSITE MEMBRANES HAVING INTRINSIC MICROPOROSITY | IP2IPO INNOVATIONS LIMITED (GB) | 2020-03-26 | — | — | US | claimed |
| CN-110676065-A | Metal crosslinked porous carbon material, and preparation method and application thereof | 华东师范大学 | 2020-01-10 | — | — | CN | claimed |
| EP-2230287-A2 | PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS, POLARIZERS AND LIQUID CRYSTAL DISPLAYS COMPRISING THE SAME | LG Chem, Ltd. (KR) | 2010-09-22 | — | — | EP | claimed |
| US-20090081589-A1 | THICK FILM RESISTS | MERCK PATENT GMBH (DE) | 2009-03-26 | — | — | US | claimed |
| US-7396895-B2 | Branched polyarylene ethers and processes for the preparation thereof | XEROX CORPORATION (US) | 2008-07-08 | — | — | US | claimed |
| US-7067608-B2 | Process for preparing branched polyarylene ethers | XEROX CORPORATION (US) | 2006-06-27 | — | — | US | claimed |
| US-20050208416-A1 | Branched polyarylene ethers and processes for the preparation thereof | XEROX CORPORATION | 2005-09-22 | — | — | US | claimed |
| US-20050154178-A1 | Process for preparing branched polyarylene ethers | XEROX CORPORATION | 2005-07-14 | — | — | US | claimed |
| US-6280923-B1 | LIGHT-INSENSITIVE SILVER SALT OF AN ORGANIC CARBOXYLIC ACID; PHOTOSENSITIVE SILVER HALIDE; BINDER; ORGANIC REDUCING AGENT FOR SAID SUBSTANTIALLY LIGHT-INSENSITIVE SILVER SALT | AGFA-GEVAERT (BE) | 2001-08-28 | — | — | US | claimed |
| US-6025515-A | STABILIZING WITH 2,6-DI-TERT-BUTYL-4-METHYLPHENOL, 3,3,3',3'-TETRAMETHYL-1,1'-SPIROBISINDANE-5,5',6,6'-TETROL, 2,6-DI-TERT-BUTYLPHENOL, 2,4,6-TRI-TERT-BUTYLPHENOL, 2,6-DI-TERT-BUTYL-4-AMINEPHENOL, 2,6-DI-TERT-BUTYLPHENOL | BAKER HUGHES INCORPORATED (US) | 2000-02-15 | — | — | US | claimed |
| EP-0669357-B1 | N-alkyl-n'-aryl-p-phenylenediamines as modifiers for epoxy resins | CIBA SC HOLDING AG (CH) | 1999-11-24 | — | — | EP | claimed |
| US-5503936-A | CURING A MIXTURE OF GLYCIDYL ETHER OR AROMATIC AMINE, A HARDENER OR CURING AGENT AND N-1,3-DIMETHYLBUTYL-N'-DIMETH-YL-BUTYL-N'- OR N,N'-BIS(1,4-DIMETHYLPENTYL-P-PHENYLENEDIAMINE; COMPOSITES; STRENGTH | CIBA-GEIGY CORPORATION (US) | 1996-04-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210284595-A1 | SPIROBIINDANE DERIVATIVES AND A PROCESS FOR PREPARATION THEREOF | REN, PKD1, PKD2 | RXRA 2515/4885FTO 3137/4885ALDH1A1 73/4885 |
| US-20230149562-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | POLN, TLR9, TSG101 | RXRA 1867/4885FTO 4694/4885ALDH1A1 3979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.